This guide includes ways to measure the effectiveness of compliance programs. Measuring compliance program effectiveness is recommended by several authorities, including the United States Sentencing Commission. This list will provide measurement options to a wide range of organizations with diverse size, operational complexity, industry sectors, resources, and compliance programs.
Since 2008, the OIG Office of Evaluation and Inspections has conducted a series of studies regarding adverse events, defined as patient harm resulting from medical care. The resulting reports describe the incidence, types, and harm level of adverse events found in various healthcare settings, including hospitals, skilled nursing facilities (SNFs), and rehabilitation hospitals. .
This toolkit is part of the OIG's award-winning Health Care Fraud Prevention and Enforcement Action Team (HEAT) Provider Compliance Training initiative. Learn how to promote quality of care and evaluate compliance program effectiveness.
OIG has developed two toolkits that provide detailed steps for using prescription drug claims data to analyze patients' opioid levels to identify certain patients at risk of opioid misuse or overdose.
Last updated August 5, 2021